Wnt modulators in the aqueous humor are associated with outer retinal damage severity in patients with neovascular age-related macular degeneration

Invest Ophthalmol Vis Sci. 2014 Jul 17;55(9):5522-30. doi: 10.1167/iovs.14-14566.

Abstract

Purpose: To investigate the associations of the Wnt modulators Wnt inhibitory factor 1 (WIF-1) and Dickkopf 3 (DKK-3) in the aqueous humor with neovascular age-related macular degeneration (nAMD) and to determine their clinical implications.

Methods: Seventy-four nAMD patients initially treated with an intravitreal injection of ranibizumab (IVR) and 74 age- and sex-matched controls were studied. Aqueous humor WIF-1 and DKK-3 levels were measured by Western blotting and an ELISA before and 1 month after two consecutive IVRs (pre- and post-IVR). Visual acuity assessments and spectral domain optical coherence tomography were performed pre- and post-IVR.

Results: Western blotting showed increased WIF-1 and DKK-3 in 12 nAMD patients compared with 12 controls. The ELISA analysis demonstrated elevated WIF-1 (pre) and DKK-3 (pre) in 62 patients compared with 62 controls (54.7 vs. 23.0 and 114.3 vs. 93.0 ng/mL, respectively). In multivariate analyses, high WIF-1 (pre) levels were associated with increased disruption in the photoreceptor junction's inner and outer segments (IS/OS) (pre and post) and high WIF-1 (post) levels. Interestingly, WIF-1 (pre) levels were significantly higher in type 3 neovascularization (NV) patients than in type 1 or 2 NV (90.5 ± 36.7 vs. 48.3 ± 22.5 and 41.3 ± 28.8 ng/mL, respectively). However, choroidal thickness was not correlated with WIF-1 levels.

Conclusions: We report, for the first time, the possibility of phenotypic, anatomic, and ocular proteomic correlations, demonstrating correlated WIF-1 and DKK-3 upregulation in nAMD patients' aqueous humor. Secreted WIF-1, reflecting the degree of retinal structure damage, may be a new biomarker for the retina's healthy and disease states.

Keywords: CNV; Wnt; age-related macular degeneration; aqueous humor; optical coherence tomography.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Signal Transducing / metabolism*
  • Aged
  • Aged, 80 and over
  • Angiogenesis Inhibitors / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Aqueous Humor / metabolism*
  • Blotting, Western
  • Case-Control Studies
  • Chemokines
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Intercellular Signaling Peptides and Proteins / metabolism*
  • Intravitreal Injections
  • Macular Degeneration / drug therapy
  • Macular Degeneration / metabolism*
  • Macular Degeneration / pathology
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Neovascularization, Pathologic / drug therapy
  • Neovascularization, Pathologic / metabolism*
  • Neovascularization, Pathologic / pathology
  • Ranibizumab
  • Repressor Proteins / metabolism*
  • Up-Regulation
  • Visual Acuity

Substances

  • Adaptor Proteins, Signal Transducing
  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • Chemokines
  • DKK3 protein, human
  • Intercellular Signaling Peptides and Proteins
  • Repressor Proteins
  • WIF1 protein, human
  • Ranibizumab